These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia. Vega GL, Toto RD, Grundy SM. Kidney Int; 1995 Feb; 47(2):579-86. PubMed ID: 7723244 [Abstract] [Full Text] [Related]
27. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria. Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P. Miner Electrolyte Metab; 1996 Feb; 22(1-3):26-30. PubMed ID: 8676820 [Abstract] [Full Text] [Related]
30. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. Davies RW, Staprans I, Hutchison FN, Kaysen GA. J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606 [Abstract] [Full Text] [Related]
31. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome. McKenzie IF, Nestel PJ. J Clin Invest; 1968 Jul; 47(7):1685-95. PubMed ID: 5658595 [Abstract] [Full Text] [Related]
32. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H. Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733 [Abstract] [Full Text] [Related]